Fennec Pharmaceuticals Inc. (FENC)
CIK 1211583 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Fennec Pharmaceuticals Inc..
Recent SEC filings
| Filed | Form | Accession number |
|---|---|---|
| Sep 1, 2026 | 144 | 0001950047-26-008901 |
| Sep 1, 2026 | 4 | 0001468316-26-000023 |
| Aug 31, 2026 | 144 | 0001950047-26-008849 |
| Aug 31, 2026 | 4 | 0002043411-26-000014 |
| Aug 31, 2026 | 4 | 0002043395-26-000012 |
| Aug 31, 2026 | 4 | 0002043317-26-000012 |
| Aug 31, 2026 | 4 | 0001926254-26-000014 |
| Aug 31, 2026 | 4 | 0001468308-26-000030 |
| Aug 28, 2026 | 4 | 0001468308-26-000028 |
| Aug 27, 2026 | 144 | 0001950047-26-008768 |
| Aug 14, 2026 | SCHEDULE 13G/A | 0001604867-26-000013 |
| Aug 14, 2026 | SCHEDULE 13G/A | 0001012975-26-000770 |
| Aug 13, 2026 | SCHEDULE 13G/A | 0001622627-26-000020 |
| Aug 13, 2026 | 10-Q | 0001104659-26-095884 |
| Aug 4, 2026 | 4 | 0001468316-26-000021 |
| Aug 3, 2026 | 4 | 0001468308-26-000026 |
| Aug 3, 2026 | 4 | 0002043395-26-000010 |
| Aug 3, 2026 | 4 | 0002043411-26-000012 |
| Aug 3, 2026 | 144 | 0001950047-26-007574 |
| Aug 3, 2026 | 4 | 0001926254-26-000012 |
| Aug 3, 2026 | 4 | 0002043317-26-000010 |
| Aug 3, 2026 | 4 | 0001468316-26-000019 |
| Jul 2, 2026 | 4 | 0001468316-26-000017 |
| Jul 1, 2026 | 4 | 0001468308-26-000024 |
| Jul 1, 2026 | 4 | 0002043317-26-000008 |